Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
MK-0591 is an inhibitor of 5-lipoxygenase-activating protein (FLAP; IC50 = 1.6 nM for the human enzyme).1 It inhibits leukotriene B4 (LTB4; Item No. 20110) biosynthesis in isolated rat neutrophils stimulated with the calcium ionophore A23187 (Item No. 11016; IC50 = 6 nM) but does not inhibit 5-lipoxygenase (5-LO) in a cell-free assay (IC50 = > 4 µM for the rat enzyme). MK-0591 (0.3 and 1 mg/kg) prevents increases in airway resistance and decreases in dynamic compliance in Ascaris antigen-induced squirrel monkeys. It decreases proteinuria and reduces decreases in renal LTC4 synthase activity in a rat model of glomerulonephritis induced by nephrotoxic rabbit serum when administered at a dose of 60 mg/kg.2 MK-0591 (8 µM) also induces apoptosis in LNCaP prostate cancer cells.3
WARNING This product is not for human or veterinary use.
1. Pharmacology of MK-
2. Inhibition of leukotriene biosynthesis improves renal function in experimental glomerulonephritis. J. Lipid Mediat. Cell Signal 11(3), 231-240 (1995).
3. MK591, a leukotriene biosynthesis inhibitor, induces apoptosis in prostate cancer cells: Synergistic action with LY294002, an inhibitor of phosphatidylinositol 3'-